Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2397-768X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy ; volume:6 ; number:1 ; day:22 ; month:9 ; year:2022 ; pages:1-8 ; date:12.2022
npj precision oncology ; 6, Heft 1 (22.9.2022), 1-8, 12.2022
- Urheber
-
Louie, Bryan H.
Kato, Shumei
Kim, Ki Hwan
Lim, Hyo Jeong
Okamura, Ryosuke
Eskander, Ramez N.
Botta, Gregory
Patel, Hitendra
Lee, Suzanna
Lippman, Scott M.
Sicklick, Jason K.
Kurzrock, Razelle
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41698-022-00309-0
- URN
-
urn:nbn:de:101:1-2022120921110323111617
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Louie, Bryan H.
- Kato, Shumei
- Kim, Ki Hwan
- Lim, Hyo Jeong
- Okamura, Ryosuke
- Eskander, Ramez N.
- Botta, Gregory
- Patel, Hitendra
- Lee, Suzanna
- Lippman, Scott M.
- Sicklick, Jason K.
- Kurzrock, Razelle
- SpringerLink (Online service)
Ähnliche Objekte (12)
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor types
Tumor-associated macrophage clusters linked to immunotherapy in a pan-cancer census
A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer
Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7
Integrated in silico analysis of LRP2 mutations to immunotherapy efficacy in pan-cancer cohort
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor types
Tumor-associated macrophage clusters linked to immunotherapy in a pan-cancer census
A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer
Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7
Integrated in silico analysis of LRP2 mutations to immunotherapy efficacy in pan-cancer cohort
NEK2 is a potential pan-cancer biomarker and immunotherapy target
Systematic pan-cancer analysis identifies ZBTB11 as a potential pan-cancer biomarker and immunotherapy target in multiple tumor types
Tumor-associated macrophage clusters linked to immunotherapy in a pan-cancer census
A comprehensive analysis of PANoptosome to prognosis and immunotherapy response in pan-cancer
Pan-cancer analysis of neoepitopes
Pan-cancer drivers of metastasis
Pan-cancer analysis reveals IGFL2 as a potential target for cancer prognosis and immunotherapy
Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy
Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy
Pan-cancer analyses of pyroptosis with functional implications for prognosis and immunotherapy in cancer
Pre-clinical validation of a pan-cancer CAR-T cell immunotherapy targeting nfP2X7